Role of antigen-specific T cells in immunotherapy-associated acute interstitial nephritis and kidney allograft rejection
抗原特异性 T 细胞在免疫治疗相关急性间质性肾炎和肾同种异体移植排斥中的作用
基本信息
- 批准号:10351987
- 负责人:
- 金额:$ 13.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-01-07 至 2023-11-30
- 项目状态:已结题
- 来源:
- 关键词:ANCA vasculitisAcuteAcute Renal Failure with Renal Papillary NecrosisAddressAffectAllograftingAnimal ModelAnimalsAntigensArchivesAutoantigensAutoimmuneAutoimmunityBiologyBiopsyBiopsy SpecimenBlood specimenCTLA4 geneCancer PatientCellsChronicClinicalClinical DataClinical ResearchClinical TrialsDataData AnalysesDialysis procedureDiseaseEnd stage renal failureEvolutionFibrosisFundingFutureGenetic TranscriptionGenomicsGoalsGraft RejectionHaptensHospitalsHumanHypersensitivityImmuneImmune ToleranceImmune checkpoint inhibitorImmune responseImmunooncologyImmunotherapyInfectionInfiltrationInflammationInflammatoryInjury to KidneyInstitutesInterstitial NephritisInvestigationKidneyKidney DiseasesKidney TransplantationLeadLymphocyteMalignant NeoplasmsMembranous GlomerulonephritisMolecularMulti-site clinical studyMultiomic DataObservational StudyOrganPatient-Focused OutcomesPatientsPeptidesPeripheral Blood Mononuclear CellPharmaceutical PreparationsPhenotypePilot ProjectsPlayProliferatingProton Pump InhibitorsProximal Kidney TubulesPublic HealthRenal Replacement TherapyResearchRiskRisk FactorsRoleSamplingSignal TransductionSpecificityStainsT cell receptor repertoire sequencingT cell responseT-Cell ActivationT-Cell ReceptorT-LymphocyteT-cell receptor repertoireTechniquesTherapeuticTissue SampleTransplant RecipientsTransplantationTumor-infiltrating immune cellsUp-RegulationWomanallograft rejectionanti-CTLA4anti-PD-1antigen-specific T cellsautoreactivitybasecancer immunotherapycheckpoint therapycomplementarity-determining region 3designdimensional analysisexperiencefeasibility testinghigh dimensionalityhuman diseasehuman tissueimmune checkpointimprovedischemic injurykidney allograftkidney biopsymortalitymultiple omicsneoantigensnephrogenesisnext generation sequencingnovelperipheral bloodpreventprogrammed cell death protein 1prospectiveresponsesingle-cell RNA sequencingtherapy developmenttumor
项目摘要
Project Summary
Cancer immunotherapy has become a standard therapy for many cancers. However, it’s associated with acute
kidney injury, resulting in significantly increased mortality. Acute interstitial nephritis is the most common acute
kidney injury, affecting 2-3% of the patients receiving immune checkpoint inhibitors (ICIs). In addition, 40% of
the kidney transplant patients receiving ICIs suffer from acute rejection, and once rejection occurs, 65% lose
allograft and require renal replacement therapy. Thus, understanding the mechanisms of ICI-associated acute
kidney injury and finding therapies is critical. My K08 project aims to understand the roles of immune
checkpoint molecules (PD-1 and CTLA-4) in kidney inflammation, by using the novel animal models that
express neoantigen peptides specifically in kidney proximal tubules and tracking antigen-specific T cell
response in the animals by tetramer staining technique. The results showed that the presence of antigen-
specific T cells and ICIs trigger the immune cell infiltration to the kidneys, mimicking acute interstitial nephritis
seen in the cancer patients treated with ICIs. While animal models are ideal to address the precise molecular
mechanisms of the disease, there’s a limitation in the applicability of the findings to the human disease. The
largest multicenter clinical study that I led recently found that the ICI-associated kidney injury occurs much
faster and more robust in kidney transplant recipients compared to non-kidney transplant patients. The findings
led to my central hypothesis that pre-existing donor antigen-specific T cells in the kidney transplant recipients
are quickly activated, proliferated in the presence of ICIs, and cause direct kidney injury. In this pilot study, I
propose to perform high dimensional analyses using human tissue samples to track antigen-specific T cells by
single cell RNA sequencing and T cell receptor (TCR) repertoire analysis. We will analyze the TCR clonotype
and phenotype of antigen-specific T cells, using the archived peripheral blood mononuclear cells, tumor and
kidney biopsy samples, obtained from the patients who had acute graft rejection after cancer ICI therapy, by
collaborating with Center of Immuno-Oncology at Dana Faber Cancer Institute and single cell genomics core at
Brigham and Women’s Hospital. This pilot project tests the feasibility of the high dimensional analysis of the
patient samples for a future prospective clinical trial in the patients with ICI-associated kidney injury. If feasible,
we will incorporate these analyses in the prospective clinical trial, which will eventually help understand the
mechanism of acute interstitial nephritis and acute graft rejection in the patients treated with cancer
immunotherapy.
项目概要
癌症免疫疗法已成为许多癌症的标准疗法,但它与急性癌症有关。
肾损伤,导致死亡率显着增加。急性间质性肾炎是最常见的急性病。
肾损伤,影响 2-3% 接受免疫检查点抑制剂 (ICIs) 治疗的患者,此外还有 40% 的患者。
接受ICIs的肾移植患者会出现急性排斥反应,一旦发生排斥反应,65%的患者会损失
同种异体移植并需要肾脏替代治疗因此,了解 ICI 相关急性的机制。
我的 K08 项目旨在了解免疫的作用。
通过使用新型动物模型,肾脏炎症中的检查点分子(PD-1 和 CTLA-4)
在肾近曲小管中特异性表达新抗原肽并追踪抗原特异性 T 细胞
通过四聚体染色技术对动物进行反应,结果表明存在抗原。
特定 T 细胞和 ICI 触发免疫细胞浸润至肾脏,类似于急性间质性肾炎
在接受 ICI 治疗的癌症患者中观察到,而动物模型是解决精确分子生物学问题的理想选择。
由于该疾病的机制,这些发现对人类疾病的适用性存在限制。
我最近领导的最大的多中心临床研究发现,ICI 相关的肾损伤发生率很高。
与非肾移植患者相比,肾移植受者的治疗速度更快、更稳健。
引出了我的中心假设:肾移植受者体内预先存在供体抗原特异性 T 细胞
在 ICI 存在的情况下会迅速激活、增殖,并导致直接肾损伤。
提议使用人体组织样本进行高维分析,以追踪抗原特异性 T 细胞
单细胞 RNA 测序和 T 细胞受体 (TCR) 库分析 我们将分析 TCR 克隆型。
使用存档的外周血单核细胞、肿瘤和抗原特异性 T 细胞的表型
肾活检样本,取自癌症 ICI 治疗后出现急性移植排斥反应的患者,
与达纳法伯癌症研究所的免疫肿瘤学中心和单细胞基因组学核心合作
布莱根妇女医院该试点项目测试了高维分析的可行性。
如果可行的话,用于未来对 ICI 相关肾损伤患者进行前瞻性临床试验的患者样本。
我们将把这些分析纳入前瞻性临床试验,这最终将有助于了解
癌症患者急性间质性肾炎及急性移植物排斥反应的机制
免疫疗法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Naoka Murakami其他文献
Naoka Murakami的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Naoka Murakami', 18)}}的其他基金
Role of antigen-specific T cells in immunotherapy-associated acute interstitial nephritis and kidney allograft rejection
抗原特异性 T 细胞在免疫治疗相关急性间质性肾炎和肾同种异体移植排斥中的作用
- 批准号:
10548204 - 财政年份:2022
- 资助金额:
$ 13.43万 - 项目类别:
Protection of kidney from autoimmunity by modulating co-stimlatory signaling
通过调节共刺激信号来保护肾脏免受自身免疫的影响
- 批准号:
10397065 - 财政年份:2019
- 资助金额:
$ 13.43万 - 项目类别:
Protection of kidney from autoimmunity by modulating co-stimlatory signaling
通过调节共刺激信号来保护肾脏免受自身免疫的影响
- 批准号:
10614441 - 财政年份:2019
- 资助金额:
$ 13.43万 - 项目类别:
Protection of kidney from autoimmunity by modulating co-stimlatory signaling
通过调节共刺激信号来保护肾脏免受自身免疫的影响
- 批准号:
9908074 - 财政年份:2019
- 资助金额:
$ 13.43万 - 项目类别:
Protection of kidney from autoimmunity by modulating co-stimlatory signaling
通过调节共刺激信号来保护肾脏免受自身免疫的影响
- 批准号:
10886997 - 财政年份:2019
- 资助金额:
$ 13.43万 - 项目类别:
相似国自然基金
巨噬细胞Nogo-B通过FABP4/IL-18/IL-18R调控急性肝衰竭的分子机制研究
- 批准号:82304503
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
α7nAChR激动剂通过PGC-1α和HO-1调控肾小管上皮细胞线粒体的质和量进而改善脓毒症急性肾损伤的机制研究
- 批准号:82372172
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于解郁散热“把好气分关”探讨代谢-炎症“开关”A2BR在急性胰腺炎既病防变中的作用与机制
- 批准号:82374256
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
RacGAP1介导细胞核-线粒体对话在急性肾损伤中促进肾小管上皮细胞能量平衡的作用机制研究
- 批准号:82300771
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
开窍寒温配伍调控应激颗粒铁离子富集水平抗急性缺血性卒中铁死亡损伤的机制研究
- 批准号:82374209
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Save Kidneys in Cisplatin Chemotherapy by blocking HDAC6
顺铂化疗中通过阻断 HDAC6 拯救肾脏
- 批准号:
10841270 - 财政年份:2023
- 资助金额:
$ 13.43万 - 项目类别:
The protective role of kidney-derived Tamm Horsfall protein (Uromodulin) in sepsis
肾源性 Tamm Horsfall 蛋白(尿调节蛋白)在脓毒症中的保护作用
- 批准号:
10886979 - 财政年份:2023
- 资助金额:
$ 13.43万 - 项目类别:
SCH: Artificial Intelligence enabled multi-modal sensor platform for at-home health monitoring of patients
SCH:人工智能支持的多模式传感器平台,用于患者的家庭健康监测
- 批准号:
10816667 - 财政年份:2023
- 资助金额:
$ 13.43万 - 项目类别:
Cell-free DNA as a versatile analyte for the monitoring of sepsis
游离 DNA 作为监测脓毒症的多功能分析物
- 批准号:
10665402 - 财政年份:2023
- 资助金额:
$ 13.43万 - 项目类别:
Delineating the kidney brain axis in children with severe malaria (KID-BRAIN)
描绘严重疟疾儿童的肾脑轴(KID-BRAIN)
- 批准号:
10734142 - 财政年份:2023
- 资助金额:
$ 13.43万 - 项目类别: